← Leaderboards
Patsy M Nishina
Jackson Laboratory
$32,323,857
Attributed
$34,596,168
Total exposure
12
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,596,168 · 12
By mechanism
R01$33,228,306 · 8
U54$858,357 · 1
T32$449,505 · 1
R13$60,000 · 2
Top collaborators
- Gregory W Carter4 shared
- Mark P Krebs4 shared
Most similar at Jackson Laboratory
Same institution · by research overlap
- Juergen K. Naggert$22,674,164
- Larry E Mobraaten$2,993,880
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesPhenotypeMouse ModelDisease PhenotypeMolecularPathway InteractionsMutationRetinal DiseasesMutantGeneticLeadAffectPathologyAnimal ModelResourcesVisionGene MutationTherapeutic TargetRetinaCommunitiesEnvironmental Risk FactorTissuesBlindnessDisease Progression
Grant awards (72)
Role of ARMS2 mutations in age-related macular degeneration$728,017
R01 · FY2025 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$700,655
R01 · FY2025 · EY · contact PI
Genetic Modifiers of Retinal Disease$616,564
R01 · FY2025 · EY · contact PI
Role of ARMS2 mutations in age-related macular degeneration$722,861
R01 · FY2024 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$703,969
R01 · FY2024 · EY · contact PI
Genetic Modifiers of Retinal Disease$616,564
R01 · FY2024 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$714,791
R01 · FY2023 · EY · contact PI
Genetic Modifiers of Retinal Disease$602,978
R01 · FY2023 · EY · contact PI
Genetic Modifiers of Retinal Disease$602,978
R01 · FY2022 · EY · contact PI
Identifying Shared Pathogenic Networks and Molecular Targets Underlying Retinal Pigmented Epithelial Associated Disease$591,579
R01 · FY2020 · EY · contact PI
Genetic Modifiers of Retinal Disease$544,593
R01 · FY2020 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$720,816
R01 · FY2019 · EY · contact PI
Identifying Shared Pathogenic Networks and Molecular Targets Underlying Retinal Pigmented Epithelial Associated Disease$603,214
R01 · FY2019 · EY · contact PI
Genetic Modifiers of Retinal Disease$544,593
R01 · FY2019 · EY · contact PI
Project 3 - Macular Degeneration Project$197,549
U54 · FY2019 · OD · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$720,816
R01 · FY2018 · EY · contact PI
Identifying Shared Pathogenic Networks and Molecular Targets Underlying Retinal Pigmented Epithelial Associated Disease$603,704
R01 · FY2018 · EY · contact PI
Genetic Modifiers of Retinal Disease$520,566
R01 · FY2018 · EY · contact PI
Project 3 - Macular Degeneration Project$198,923
U54 · FY2018 · OD · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$125,680
R01 · FY2018 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$720,816
R01 · FY2017 · EY · contact PI
Identifying Shared Pathogenic Networks and Molecular Targets Underlying Retinal Pigmented Epithelial Associated Disease$615,807
R01 · FY2017 · EY · contact PI
Genetic Modifiers of Retinal Disease$520,566
R01 · FY2017 · EY · contact PI
Project 3 - Macular Degeneration Project$184,279
U54 · FY2017 · OD · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$690,911
R01 · FY2016 · EY · contact PI
Project 3 - Macular Degeneration Project$162,543
U54 · FY2016 · OD · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$690,911
R01 · FY2015 · EY · contact PI
Project 3 - Macular Degeneration Project$115,063
U54 · FY2015 · OD · contact PI
Models for Vision Research$941,291
R01 · FY2014 · EY · contact PI
Models for Vision Research$933,566
R01 · FY2013 · EY · contact PI
Models for Vision Research$982,702
R01 · FY2012 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$593,222
R01 · FY2012 · EY · contact PI
Models for Vision Research$255,264
R01 · FY2012 · EY · contact PI
Models for Vision Research$982,702
R01 · FY2011 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$593,222
R01 · FY2011 · EY · contact PI
Models for Vision Research$993,798
R01 · FY2010 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$599,943
R01 · FY2010 · EY · contact PI
Models for Vision Research$165,250
R01 · FY2010 · EY · contact PI
Models for Vision Research$832,301
R01 · FY2009 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$588,352
R01 · FY2009 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$242,680
R01 · FY2009 · EY · contact PI
Models for Vision Research$792,274
R01 · FY2008 · EY · contact PI
Retinal Disease: Molecular Basis and Pathophysiology$571,215
R01 · FY2008 · EY · contact PI
Models for Vision Research$185,204
R01 · FY2008 · EY · contact PI
Models for Vision Research$785,275
R01 · FY2007 · EY · contact PI
Models for Vision Research$767,079
R01 · FY2006 · EY · contact PI
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$397,924
R01 · FY2006 · EY · contact PI
The Laboratory Mouse in Vision Research II$37,500
R13 · FY2006 · EY · contact PI
Mouse Models for Vision Research$763,055
R01 · FY2005 · EY
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$407,500
R01 · FY2005 · EY
Molecular Genetics of Muscular/Neurosensory Models$387,125
R01 · FY2005 · NS
Molecular Genetic Characterization of Alstrom Syndrome$330,075
R01 · FY2005 · HD
Training in Mouse and Molecular Genetics of the Eye$112,888
T32 · FY2005 · EY
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$407,500
R01 · FY2004 · EY
Molecular Genetics of Muscular/Neurosensory Models$387,125
R01 · FY2004 · NS
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$330,654
R01 · FY2004 · EY
Molecular Genetic Characterization of Alstrom Syndrome$330,075
R01 · FY2004 · HD
Training in Mouse and Molecular Genetics of the Eye$112,784
T32 · FY2004 · EY
The Laboratory Mouse in Vision Research$22,500
R13 · FY2004 · EY
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$407,500
R01 · FY2003 · EY
Molecular Genetics of Muscular/Neurosensory Models$387,125
R01 · FY2003 · NS
Molecular Genetic Characterization of Alstrom Syndrome$330,075
R01 · FY2003 · HD
Training in Mouse and Molecular Genetics of the Eye$111,518
T32 · FY2003 · EY
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$74,156
R01 · FY2003 · EY
RETINAL DISEASE: MOLECULAR BASIS AND PATHOPHYSIOLOGY$407,916
R01 · FY2002 · EY
Molecular Genetics of Muscular/Neurosensory Models$387,323
R01 · FY2002 · NS
Molecular Genetic Characterization of Alstrom Syndrome$330,075
R01 · FY2002 · HD
Training in Mouse and Molecular Genetics of the Eye$112,315
T32 · FY2002 · EY
Molecular Genetic Characterization of Alstrom Syndrome$330,835
R01 · FY2001 · HD
MOLECULAR GENETIC CHARACTERIZATION OF ALSTROM SYNDROME$304,923
R01 · FY2000 · HD
RETINAL DISEASE--MOLECULAR BASIS AND PATHOPHYSIOLOGY$277,839
R01 · FY2000 · EY
P53--ROLE IN DEVELOPMENT &NEOVASCULARIZATION OF THE EYE$220,217
R01 · FY2000 · EY